Nestlé Developing Microbiome-Based Supplements with Dutch Partner

25 Nov 2019

Nestlé Health Science is putting its financial weight behind the Netherlands' Caelus Health to help commercialize microbiome-based food supplements for early intervention in a number of diseases.

Nestle Health Science SA has entered into a strategic collaboration with Netherlands-based Caelus Health to develop microbiome-based food supplements for the prevention and early treatment of cardio-metabolic diseases.

Under the terms of a global development and option agreement signed by both firms, Nestlé has agreed to fund Caelus’ efforts to further pursue the preclinical and clinical development of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

OTC Marketing Awards 2025 Open For Entries

21 May 2025

• By Tom Gallen

Find out how to enter the OTC Marketing Awards before the 1 September entry deadline.

Haleon Utilizing AI To Develop Natural CHC Products

09 May 2025

• By Tom Gallen

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

Givaudan Has UTI Health Claim Turned Down In EU

08 Apr 2025

• By Tom Gallen

European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.

Principle Relaunches Vitawell To Help Consumers Navigate UK Supplement ‘Minefield’

27 Mar 2025

• By Tom Gallen

Vitawell seeking to empower consumers left confused by the vast array of dietary supplements available to them in the UK.

US FDA Supplement Office Chief Eyes ‘Movement’ This Year On NDI Notifications Final Guidance

20 May 2025

• By Malcolm Spicer

“We've made some progress and really hope to see some movement as we move forward this year,” says FDA Office of Dietary Supplement Programs director Cara Welch.